Continuous versus intermittent antibiotics for bronchiectasis.
CONCLUSIONS: No randomised controlled trials have compared the effectiveness and risks of continuous antibiotic therapy versus intermittent antibiotic therapy for bronchiectasis. High-quality clinical trials are needed to establish which of these interventions is more effective for reducing the frequency and duration of exacerbations, antibiotic resistance and the occurrence of serious adverse events.
PMID: 29860722 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S Tags: Cochrane Database Syst Rev Source Type: research
More News: Antibiotic Therapy | Child Development | Children | Clinical Trials | Conferences | Databases & Libraries | General Medicine | International Medicine & Public Health | Study | WHO